HuGE Literature Finder
Records
1
-
2
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer. Prostate cancer and prostatic diseases 2021 6 24 (4): 1167-1180. McCoy Patrick, Mangiola Stefano, Macintyre Geoff, Hutchinson Ryan, Tran Ben, Pope Bernard, Georgeson Peter, Hong Matthew K H, Kurganovs Natalie, Lunke Sebastian, Clarkson Michael J, Cmero Marek, Kerger Michael, Stuchbery Ryan, Chow Ken, Haviv Izhak, Ryan Andrew, Costello Anthony J, Corcoran Niall M, Hovens Christopher |
Mismatch Repair-Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 3 26 (13): 3271-3279. Cercek Andrea, Dos Santos Fernandes Gustavo, Roxburgh Campbell S, Ganesh Karuna, Ng Shu, Sanchez-Vega Francisco, Yaeger Rona, Segal Neil H, Reidy-Lagunes Diane L, Varghese Anna M, Markowitz Arnold, Wu Chao, Szeglin Bryan, Sauvé Charles-Etienne Gabriel, Salo-Mullen Erin, Tran Christina, Patel Zalak, Krishnan Asha, Tkachuk Kaitlyn, Nash Garrett M, Guillem Jose, Paty Philip B, Shia Jinru, Schultz Nikolaus, Garcia-Aguilar Julio, Diaz Luis A, Goodman Karyn, Saltz Leonard B, Weiser Martin R, Smith J Joshua, Stadler Zsofia |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: